Manuscript Writing Service
International Journal of Clinical Obstetrics and Gynaecology

International Journal of Clinical Obstetrics and Gynaecology

Print ISSN: 2522-6614, Online ISSN: 2522-6622

International Journal of Clinical Obstetrics and Gynaecology

2019, Vol. 3, Issue 2, Part D

Ormeloxifene in the management of AUB
Author(s): Kanchan Nisha and Prajwala A
Abstract: Objective: To study the efficacy and safety of ormeloxifene in the medical management of AUB.
Methods: 50 women with HMB who satisfied inclusion criteria were included in the study. Ormeloxifene 60 mg tablet twice a week for the first 12 weeks and then once a week for 12 weeks was given for every patient. The outcome was assessed by assessment of menstrual blood flow by PBAC score, Hb level and endometrial thickness
Results: The PBAC score was significantly reduced in 85 % of patients. The mean Hb concentration was significantly increased from 8.6 to 11.8 g/dl. The mean endometrial thickness was reduced from 10.14 mm to 7.35 mm
Conclusion: Ormeloxifene is an effective and user friendly drug for medical management of AUB.
Pages: 229-230 | 942 Views | 198 Downloads
Download Full Article: Click Here
How to cite this article:
Kanchan Nisha, Prajwala A. Ormeloxifene in the management of AUB. Int J Clin Obstet Gynaecol 2019;3(2):229-230. DOI: 10.33545/gynae.2019.v3.i2d.41
International Journal of Clinical Obstetrics and Gynaecology